Literature DB >> 30296860

Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown.

Mohammad A Obeid1,2, Christine Dufès2, Sukrut Somani2, Alexander B Mullen2, Rothwelle J Tate2, Valerie A Ferro2.   

Abstract

RNA interference is an effective and naturally occurring post-transcriptional gene regulatory mechanism. This mechanism involves the degradation of a target messenger RNA (mRNA) through the introduction of short interfering RNA (siRNA) that is complementary to the target mRNA. The application of siRNA-based therapeutics is limited by the development of an effective delivery system, as naked siRNA is unstable and cannot penetrate the cell membrane. In this study, we investigated the use of cationic niosomes (CN) prepared by microfluidic mixing for siRNA delivery. In an in vitro model, these vesicles were able to deliver anti-luciferase siRNA and effectively suppress luciferase expression in B16-F10 mouse melanoma cells. More importantly, in an in vivo mouse model, intratumoral administration of CN-carrying anti-luciferase siRNA led to significant suppression of luciferase expression compared with naked siRNA. Thus, we have established a novel and effective system for the delivery of siRNA both in vitro and in vivo, which shows high potential for future application of gene therapeutics.

Entities:  

Keywords:  Niosomes; RNA interference; drug delivery; microfluidics; nanoparticles

Mesh:

Substances:

Year:  2019        PMID: 30296860     DOI: 10.1080/08982104.2018.1531424

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  2 in total

1.  Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release.

Authors:  Mohammad A Obeid; Ibrahim Khadra; Abdullah Albaloushi; Margaret Mullin; Hanin Alyamani; Valerie A Ferro
Journal:  Beilstein J Nanotechnol       Date:  2019-09-05       Impact factor: 3.649

Review 2.  SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments.

Authors:  Adedapo Adesokan; Mohammad A Obeid; Aisha F Lawal
Journal:  Ther Deliv       Date:  2022-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.